New software
Colin Kerr
Published: Thursday, September 1, 2016
[caption id="attachment_6223" align="alignnone" width="1890"]
New software for combined tomographic and biomechanical assessment[/caption]
The OCULUS Corvis® ST combines tonometry and pachymetry with the biomechanical response of the cornea in a new and exciting way, the company says.
“It is the first instrument enabling ophthalmologists to perform fast and comprehensive screenings for biomechanically weak corneas,” said a company spokeswoman.
“Furthermore, the integration of Pentacam® data allows combining biomechanical and tomographic data for a more efficient and safer screening prior to refractive surgery,” she added.
www.corneal-biomechanics.de
NEW GENERATION
Vitreq has launched a new generation of vitrectomy lenses.
“Comprised of optically crystal-clear PMMA, Vitreq’s vitrectomy lenses have a high refraction index, creating excellent intraocular visualisation,” said a company spokesman.
“A highly stable position on the eye can be achieved thanks to a flexible silicone ring (injection), moulded with four surrounding haptics,” he added. There is a range of lenses for any surgical needs requiring specific, enhanced visualisation in the posterior of the eye. A 30o prism provides a clearer view of posterior peripheral fundus/vitreous beyond equator in phakic, aphakic and pseudophakic eyes.
www.vitreq.com
CE MARK
Eyenuk Inc., developer of advanced retinal image analysis solutions to identify eye disease, has announced receipt of the CE Mark and the launch of the second generation of its EyeArt fully automated diabetic retinopathy (DR) screening software.
The company plans to roll out EyeArt 2.0 to selected, leading eye care centres in Europe over the next few months, said a company spokesman.
The commercial launch is supported by a new study of the EyeArt 2.0 technology, which demonstrated 98.3 per cent sensitivity in identifying potentially treatable patients with severe non-proliferative or proliferative DR, and/or the presence of surrogate markers for CSME.
www.eyenuk.com
New software for combined tomographic and biomechanical assessment[/caption]
The OCULUS Corvis® ST combines tonometry and pachymetry with the biomechanical response of the cornea in a new and exciting way, the company says.
“It is the first instrument enabling ophthalmologists to perform fast and comprehensive screenings for biomechanically weak corneas,” said a company spokeswoman.
“Furthermore, the integration of Pentacam® data allows combining biomechanical and tomographic data for a more efficient and safer screening prior to refractive surgery,” she added.
www.corneal-biomechanics.de
NEW GENERATION
Vitreq has launched a new generation of vitrectomy lenses.
“Comprised of optically crystal-clear PMMA, Vitreq’s vitrectomy lenses have a high refraction index, creating excellent intraocular visualisation,” said a company spokesman.
“A highly stable position on the eye can be achieved thanks to a flexible silicone ring (injection), moulded with four surrounding haptics,” he added. There is a range of lenses for any surgical needs requiring specific, enhanced visualisation in the posterior of the eye. A 30o prism provides a clearer view of posterior peripheral fundus/vitreous beyond equator in phakic, aphakic and pseudophakic eyes.
www.vitreq.com
CE MARK
Eyenuk Inc., developer of advanced retinal image analysis solutions to identify eye disease, has announced receipt of the CE Mark and the launch of the second generation of its EyeArt fully automated diabetic retinopathy (DR) screening software.
The company plans to roll out EyeArt 2.0 to selected, leading eye care centres in Europe over the next few months, said a company spokesman.
The commercial launch is supported by a new study of the EyeArt 2.0 technology, which demonstrated 98.3 per cent sensitivity in identifying potentially treatable patients with severe non-proliferative or proliferative DR, and/or the presence of surrogate markers for CSME.
www.eyenuk.com
Tags: imaging, industry, lenses, new products
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Best of ESCRS Winter Meeting 2024
Following the New Generation
EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.
Refocus on Multifocals
Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.
Common Myths in Presbyopia Correction
Patient education key to satisfaction with refractive IOLs.
Reversible Multifocality
Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.
Managing a Cataract Surgery Refractive Miss
Weighing the pros and cons of options for intraocular intervention.
Unleashing OCT’s Full Potential
Performance of newest tool for corneal evaluation meets or beats older standard technologies.